Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CTI is a private, global full-service contract research organization serving pharmaceutical, biotechnology, and medical device sponsors across the clinical development lifecycle. Founded in 1999, the company provides regulatory consulting, clinical operations, real-world evidence, central laboratory services, and an in-house clinical research center that conducts Phase I-IV studies. CTI has particular depth in rare disease, cell and gene therapy, immunology, transplantation, nephrology, neurology, and vaccine-related programs. Rather than advancing a proprietary drug pipeline, CTI operates as a service partner helping sponsors move programs from early development through approval and commercialization. The company also maintains global operations, with employees working in more than 60 countries and headquarters in Covington, Kentucky.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CTI Clinical Research Center.